STOCK TITAN

[Form 4] Clorox Company Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Clarivate Plc (CLVT) – Form 4 insider transaction filed 07/02/2025.

Director Andrew M. Snyder reported routine quarterly equity compensation in lieu of a cash retainer. On 06/30/2025 he acquired 11,918 ordinary shares at the 06/30/2025 closing price of $4.30, equivalent to the $51,250 board fee. To cover withholding taxes, 527 shares were surrendered at the same price. After these transactions Mr. Snyder holds 164,489 shares directly.

In addition, Snyder has large indirect holdings totalling 24,374,148 shares through Cambridge Information Group entities and a family trust, though he disclaims beneficial ownership beyond his pecuniary interest.

No options or other derivative securities were reported. The filing reflects normal director compensation rather than a discretionary open-market purchase, so market impact is expected to be minimal.

Clarivate Plc (CLVT) – Transazione interna Form 4 depositata il 02/07/2025.

Il direttore Andrew M. Snyder ha segnalato una consueta compensazione trimestrale in azioni in sostituzione del compenso in contanti. Il 30/06/2025 ha acquisito 11.918 azioni ordinarie al prezzo di chiusura del 30/06/2025 di $4,30, equivalente al compenso di $51.250 per il consiglio di amministrazione. Per coprire le imposte alla fonte, sono state cedute 527 azioni allo stesso prezzo. Dopo queste operazioni, il signor Snyder detiene 164.489 azioni direttamente.

Inoltre, Snyder possiede ingenti partecipazioni indirette per un totale di 24.374.148 azioni attraverso entità del Cambridge Information Group e un trust familiare, pur negando la titolarità effettiva oltre al suo interesse patrimoniale.

Non sono state segnalate opzioni o altri strumenti derivati. Il deposito riflette una normale compensazione da direttore piuttosto che un acquisto discrezionale sul mercato aperto, pertanto l'impatto sul mercato è previsto minimo.

Clarivate Plc (CLVT) – Transacción interna Formulario 4 presentada el 02/07/2025.

El director Andrew M. Snyder reportó una compensación trimestral rutinaria en acciones en lugar de una remuneración en efectivo. El 30/06/2025 adquirió 11,918 acciones ordinarias al precio de cierre del 30/06/2025 de $4.30, equivalente a la tarifa de $51,250 por su cargo en la junta. Para cubrir impuestos retenidos, se entregaron 527 acciones al mismo precio. Tras estas transacciones, el Sr. Snyder posee 164,489 acciones directamente.

Además, Snyder tiene grandes participaciones indirectas que suman 24,374,148 acciones a través de entidades de Cambridge Information Group y un fideicomiso familiar, aunque niega la propiedad beneficiaria más allá de su interés económico.

No se reportaron opciones ni otros valores derivados. La presentación refleja una compensación normal del director en lugar de una compra discrecional en el mercado abierto, por lo que se espera un impacto mínimo en el mercado.

Clarivate Plc (CLVT) – 2025년 7월 2일 제출된 Form 4 내부자 거래 보고서.

이사 Andrew M. Snyder는 현금 보수 대신 정기 분기별 주식 보상을 보고했습니다. 2025년 6월 30일에 그는 6월 30일 종가인 $4.3011,918주 보통주를 취득했으며, 이는 $51,250의 이사회 수수료에 해당합니다. 원천징수세를 충당하기 위해 527주를 같은 가격에 반납했습니다. 이 거래 후 Snyder 씨는 직접 164,489주를 보유하고 있습니다.

또한, Snyder는 Cambridge Information Group 계열사와 가족 신탁을 통해 총 24,374,148주의 간접 보유 지분을 보유하고 있으나, 경제적 이해관계 외에는 실질적 소유권을 부인하고 있습니다.

옵션이나 기타 파생 증권은 보고되지 않았습니다. 이번 신고는 임의의 공개 시장 매수가 아닌 정상적인 이사 보상을 반영하므로 시장에 미치는 영향은 미미할 것으로 예상됩니다.

Clarivate Plc (CLVT) – Déclaration Formulaire 4 d’initié déposée le 02/07/2025.

Le directeur Andrew M. Snyder a déclaré une rémunération trimestrielle en actions en lieu et place d’une retenue en espèces. Le 30/06/2025, il a acquis 11 918 actions ordinaires au cours de clôture du 30/06/2025 de 4,30 $, équivalant aux honoraires de 51 250 $ pour le conseil d’administration. Pour couvrir les impôts retenus à la source, 527 actions ont été cédées au même prix. Après ces opérations, M. Snyder détient 164 489 actions en direct.

De plus, Snyder possède d’importantes participations indirectes totalisant 24 374 148 actions via des entités du Cambridge Information Group et un trust familial, bien qu’il décline la propriété bénéficiaire au-delà de son intérêt pécuniaire.

Aucune option ni autre titre dérivé n’a été rapporté. Le dépôt reflète une rémunération normale de directeur plutôt qu’un achat discrétionnaire sur le marché libre, donc l’impact sur le marché devrait être minimal.

Clarivate Plc (CLVT) – Form 4 Insider-Transaktion eingereicht am 02.07.2025.

Direktor Andrew M. Snyder meldete eine routinemäßige vierteljährliche Aktienvergütung anstelle einer Barvergütung. Am 30.06.2025 erwarb er 11.918 Stammaktien zum Schlusskurs vom 30.06.2025 von 4,30 $, entsprechend der Vorstandshonorarzahlung von 51.250 $. Zur Deckung der Quellensteuer wurden 527 Aktien zum selben Preis abgegeben. Nach diesen Transaktionen hält Herr Snyder 164.489 Aktien direkt.

Zusätzlich besitzt Snyder umfangreiche indirekte Beteiligungen in Höhe von 24.374.148 Aktien über Cambridge Information Group-Einheiten und einen Familientrust, bestreitet jedoch eine wirtschaftliche Eigentümerschaft über sein finanzielles Interesse hinaus.

Es wurden keine Optionen oder andere derivative Wertpapiere gemeldet. Die Meldung spiegelt eine normale Vergütung des Direktors wider und keinen diskretionären Kauf am offenen Markt, sodass der Markteinfluss voraussichtlich gering ist.

Positive
  • Equity-based director compensation increases alignment between board and shareholders, adding 11,918 shares to the director’s direct stake.
Negative
  • Immaterial size of the transaction (~$51k) limits any positive signaling value to the market.

Insights

TL;DR: Routine board stock award; negligible immediate valuation impact.

The $51k share award is immaterial relative to Clarivate’s daily trading volume and Snyder’s existing 24.5 million-share indirect stake. The direct holding increase aligns director incentives with shareholders but does not change ownership concentration or signal new information about company fundamentals. The tax-withholding disposal is mechanical. Overall, neutral for valuation and liquidity.

TL;DR: Standard equity retainer supports pay-for-performance model; no governance red flags.

Clarivate continues to compensate directors with equity, reinforcing long-term alignment. Snyder’s large indirect holdings via Cambridge Information Group already give him significant exposure, so additional 11.9k shares are symbolic. Proper Rule 10b5-1 checkbox appears unchecked, implying discretionary timing but still routine. No related-party transactions or unusual structures noted; disclosure is complete and timely.

Clarivate Plc (CLVT) – Transazione interna Form 4 depositata il 02/07/2025.

Il direttore Andrew M. Snyder ha segnalato una consueta compensazione trimestrale in azioni in sostituzione del compenso in contanti. Il 30/06/2025 ha acquisito 11.918 azioni ordinarie al prezzo di chiusura del 30/06/2025 di $4,30, equivalente al compenso di $51.250 per il consiglio di amministrazione. Per coprire le imposte alla fonte, sono state cedute 527 azioni allo stesso prezzo. Dopo queste operazioni, il signor Snyder detiene 164.489 azioni direttamente.

Inoltre, Snyder possiede ingenti partecipazioni indirette per un totale di 24.374.148 azioni attraverso entità del Cambridge Information Group e un trust familiare, pur negando la titolarità effettiva oltre al suo interesse patrimoniale.

Non sono state segnalate opzioni o altri strumenti derivati. Il deposito riflette una normale compensazione da direttore piuttosto che un acquisto discrezionale sul mercato aperto, pertanto l'impatto sul mercato è previsto minimo.

Clarivate Plc (CLVT) – Transacción interna Formulario 4 presentada el 02/07/2025.

El director Andrew M. Snyder reportó una compensación trimestral rutinaria en acciones en lugar de una remuneración en efectivo. El 30/06/2025 adquirió 11,918 acciones ordinarias al precio de cierre del 30/06/2025 de $4.30, equivalente a la tarifa de $51,250 por su cargo en la junta. Para cubrir impuestos retenidos, se entregaron 527 acciones al mismo precio. Tras estas transacciones, el Sr. Snyder posee 164,489 acciones directamente.

Además, Snyder tiene grandes participaciones indirectas que suman 24,374,148 acciones a través de entidades de Cambridge Information Group y un fideicomiso familiar, aunque niega la propiedad beneficiaria más allá de su interés económico.

No se reportaron opciones ni otros valores derivados. La presentación refleja una compensación normal del director en lugar de una compra discrecional en el mercado abierto, por lo que se espera un impacto mínimo en el mercado.

Clarivate Plc (CLVT) – 2025년 7월 2일 제출된 Form 4 내부자 거래 보고서.

이사 Andrew M. Snyder는 현금 보수 대신 정기 분기별 주식 보상을 보고했습니다. 2025년 6월 30일에 그는 6월 30일 종가인 $4.3011,918주 보통주를 취득했으며, 이는 $51,250의 이사회 수수료에 해당합니다. 원천징수세를 충당하기 위해 527주를 같은 가격에 반납했습니다. 이 거래 후 Snyder 씨는 직접 164,489주를 보유하고 있습니다.

또한, Snyder는 Cambridge Information Group 계열사와 가족 신탁을 통해 총 24,374,148주의 간접 보유 지분을 보유하고 있으나, 경제적 이해관계 외에는 실질적 소유권을 부인하고 있습니다.

옵션이나 기타 파생 증권은 보고되지 않았습니다. 이번 신고는 임의의 공개 시장 매수가 아닌 정상적인 이사 보상을 반영하므로 시장에 미치는 영향은 미미할 것으로 예상됩니다.

Clarivate Plc (CLVT) – Déclaration Formulaire 4 d’initié déposée le 02/07/2025.

Le directeur Andrew M. Snyder a déclaré une rémunération trimestrielle en actions en lieu et place d’une retenue en espèces. Le 30/06/2025, il a acquis 11 918 actions ordinaires au cours de clôture du 30/06/2025 de 4,30 $, équivalant aux honoraires de 51 250 $ pour le conseil d’administration. Pour couvrir les impôts retenus à la source, 527 actions ont été cédées au même prix. Après ces opérations, M. Snyder détient 164 489 actions en direct.

De plus, Snyder possède d’importantes participations indirectes totalisant 24 374 148 actions via des entités du Cambridge Information Group et un trust familial, bien qu’il décline la propriété bénéficiaire au-delà de son intérêt pécuniaire.

Aucune option ni autre titre dérivé n’a été rapporté. Le dépôt reflète une rémunération normale de directeur plutôt qu’un achat discrétionnaire sur le marché libre, donc l’impact sur le marché devrait être minimal.

Clarivate Plc (CLVT) – Form 4 Insider-Transaktion eingereicht am 02.07.2025.

Direktor Andrew M. Snyder meldete eine routinemäßige vierteljährliche Aktienvergütung anstelle einer Barvergütung. Am 30.06.2025 erwarb er 11.918 Stammaktien zum Schlusskurs vom 30.06.2025 von 4,30 $, entsprechend der Vorstandshonorarzahlung von 51.250 $. Zur Deckung der Quellensteuer wurden 527 Aktien zum selben Preis abgegeben. Nach diesen Transaktionen hält Herr Snyder 164.489 Aktien direkt.

Zusätzlich besitzt Snyder umfangreiche indirekte Beteiligungen in Höhe von 24.374.148 Aktien über Cambridge Information Group-Einheiten und einen Familientrust, bestreitet jedoch eine wirtschaftliche Eigentümerschaft über sein finanzielles Interesse hinaus.

Es wurden keine Optionen oder andere derivative Wertpapiere gemeldet. Die Meldung spiegelt eine normale Vergütung des Direktors wider und keinen diskretionären Kauf am offenen Markt, sodass der Markteinfluss voraussichtlich gering ist.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Breber Pierre R

(Last) (First) (Middle)
1221 BROADWAY

(Street)
OAKLAND CA 94612-1888

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Units (1) 05/09/2025 A(2) V 2.2874 (3) (3) Common Stock 2.2874 $0.0000 254.9509 D
Deferred Stock Units (1) 06/30/2025 A(4) 242.0749 (3) (3) Common Stock 242.0749 $0.0000 497.0258 D
Explanation of Responses:
1. 1-for-1
2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.
By Cheryl Brice, Attorney-in-Fact for 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Clarivate (CLVT) shares did Andrew Snyder acquire on 06/30/2025?

He received 11,918 ordinary shares as a quarterly retainer.

What was the price used to calculate the share award?

The award was based on the $4.30 closing price of CLVT on 06/30/2025.

Why were 527 shares disposed of on the same date?

These shares were withheld to cover taxes on the equity award.

How many CLVT shares does Snyder now own directly?

After the transaction he holds 164,489 shares directly.

Does Snyder have additional indirect ownership in CLVT?

Yes, he has 24,374,148 shares held via various Cambridge Information Group entities and a family trust, subject to pecuniary disclaimers.

Are any derivative securities reported in this Form 4?

No derivative securities were acquired or disposed of in this filing.
Clorox Co Del

NYSE:CLX

CLX Rankings

CLX Latest News

CLX Latest SEC Filings

CLX Stock Data

14.55B
123.00M
0.19%
83%
3.51%
Household & Personal Products
Specialty Cleaning, Polishing and Sanitation Preparations
Link
United States
OAKLAND